首页> 外文期刊>BMC Gastroenterology >The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study
【24h】

The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study

机译:内镜超声探头发现对肝硬化患者内镜静脉曲张根除治疗后食管静脉曲张复发的预测:一项队列前瞻性研究

获取原文
           

摘要

The recurrence of esophageal varices remains high in patients with hepatic portal hypertension after the endoscopic esophageal variceal eradication therapies, including endoscopic variceal band ligation (EVL), injection sclerotherapy (EIS) or EVL plus EIS. The aim of this study was to evaluate the endoscopic ultrasound probe examinations (EUP) findings in the prediction of recurrence following esophageal variceal eradication in a prospective cohort. A total of 206 cirrhotic portal hypertension patients with esophageal variceal eradication, who underwent endoscopic variceal therapy (EVL or EIS or EVL plus EIS) were initially enrolled. All patients were scheduled for a follow-up every 6?months for up to 3?years. EUP was performed to evaluate peri-esophageal collateral veins (peri-ECVs), perforating veins (PFV) and para-esophageal collateral veins (para-ECVs). In addition, computed tomography (CT) were conducted to detect portal vein diameter, portal vein embolus, and major portosystemic collateral shunts. The relationship between esophageal variceal recurrence and EUP findings were analyzed. We found that as high as 93.5% of patients developed esophageal variceal recurrence in the 3-year follow-up. The time of esophageal variceal recurrence after variceal eradication was 13.4?months (13.4?±?9.2?months). Furthermore, the median time of recurrence in patients who were undertaken EVL,EIS and EVL plus EIS was 10, 13 and 12?months, respectively. We identified that the risk factors, including EVL (OR 0.23, 95% CI 0.08–0.71, p??0.01), Child-Pugh score (OR 3.32,95% CI 1.31–35.35, p??0.05), large peri-ECVs (OR 4.56, 95% CI 2.17–9.58, p??0.0001), and existence of PFV (OR 2.14, 95% CI 1.44–3.16, p??0.001), were significantly associated with the recurrence of esophageal varices. The peri-ECVs and PFV showed better ability to predict esophageal variceal recurrence. When cut-off value of peri-ECVs diameter was 3.5?mm, the specificity of prediction 1-year variceal recurrence was 86% and the sensitivity was 45%. The EUP appears to be very effective, convenient and economical examinations to predict esophageal varices recurrence after variceal eradication by endoscopic therapies. The high Child-pugh score, large peri-ECVs, and PFV are independent risk factors related to esophageal varices recurrence.
机译:内镜食管静脉曲张根除术包括内镜下静脉曲张带结扎术(EVL),注射硬化疗法(EIS)或EVL加EIS后,肝门静脉高压症患者的食管静脉曲张复发率仍然很高。这项研究的目的是评估内镜超声探头检查(EUP)的发现,以预测未来人群中食管静脉曲张根除后的复发。最初共纳入了206例接受内镜静脉曲张治疗(EVL或EIS或EVL加EIS)的根除食管静脉曲张的肝硬化门脉高压患者。所有患者均计划每6个月进行一次随访,最长3年。进行EUP评估食管周围副静脉(peri-ECV),穿孔静脉(PFV)和食管旁副静脉(para-ECV)。此外,进行计算机断层扫描(CT)以检测门静脉直径,门静脉栓子和主要的门体侧支分流。分析了食管静脉曲张复发与EUP发现之间的关系。我们发现在3年的随访中,高达93.5%的患者发生了食管静脉曲张复发。根除静脉曲张后的食管静脉曲张复发时间为13.4?月(13.4?±?9.2?月)。此外,接受EVL,EIS和EVL加EIS的患者的中位复发时间分别为10、13和12个月。我们发现危险因素,包括EVL(OR 0.23,95%CI 0.08-0.71,p?<?0.01),Child-Pugh评分(OR 3.32,95%CI 1.31-35.35,p?<?0.05),均很大。 ECV周围(OR 4.56,95%CI 2.17–9.58,p?<?0.0001)和PFV的存在(OR 2.14,95%CI 1.44–3.16,p?<?0.001)与复发有关。食管静脉曲张。 ECVs和PFV周围显示出更好的预测食管静脉曲张复发的能力。当ECV周围直径的临界值为3.5?mm时,预测的1年静脉曲张复发的特异性为86%,敏感性为45%。 EUP似乎是一种非常有效,方便且经济的检查方法,可以通过内窥镜治疗根除静脉曲张后预测食管静脉曲张的复发。 Child-pugh评分高,ECV大和PFV是与食管静脉曲张复发相关的独立危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号